Evaluation of the effect of necitumumab on the corrected QT interval in patients with advanced solid tumors.
Saved in:
| Title: | Evaluation of the effect of necitumumab on the corrected QT interval in patients with advanced solid tumors. |
|---|---|
| Authors: | Smith DC; University of Michigan, 1500 E Medical Center Drive SPC 5913, Ann Arbor, MI, 48109, USA. dcsmith@med.umich.edu., Powderly J; Carolina BioOncology Institute, Huntersville, NC, USA., Lee JJ; University of Pittsburgh, Pittsburgh, PA, USA., Shepard DR; Cleveland Clinic Foundation, Cleveland, OH, USA., Wallin J; Eli Lilly and Company, Solna, Sweden., Chaudhary A; Eli Lilly and Company, Indianapolis, IN, USA., Chao GY; Eli Lilly and Company, Indianapolis, IN, USA., Ng WT; Eil Lilly-NUS, Singapore, Singapore., Mitchell MI; Eli Lilly and Company, Windlesham, Surrey, UK., Grau G; Eli Lilly and Company, Bad Homburg, Germany., Kurek R; Eli Lilly and Company, Bad Homburg, Germany., LoRusso P; Yale University, New Haven, CT, USA. |
| Source: | Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2016 Aug; Vol. 78 (2), pp. 271-80. Date of Electronic Publication: 2016 Jun 16. |
| Publication Type: | Clinical Trial, Phase II; Journal Article; Multicenter Study |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 27312733 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Evaluation of the effect of necitumumab on the corrected QT interval in patients with advanced solid tumors. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Smith+DC%22">Smith DC</searchLink>; University of Michigan, 1500 E Medical Center Drive SPC 5913, Ann Arbor, MI, 48109, USA. dcsmith@med.umich.edu.<br /><searchLink fieldCode="AU" term="%22Powderly+J%22">Powderly J</searchLink>; Carolina BioOncology Institute, Huntersville, NC, USA.<br /><searchLink fieldCode="AU" term="%22Lee+JJ%22">Lee JJ</searchLink>; University of Pittsburgh, Pittsburgh, PA, USA.<br /><searchLink fieldCode="AU" term="%22Shepard+DR%22">Shepard DR</searchLink>; Cleveland Clinic Foundation, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Wallin+J%22">Wallin J</searchLink>; Eli Lilly and Company, Solna, Sweden.<br /><searchLink fieldCode="AU" term="%22Chaudhary+A%22">Chaudhary A</searchLink>; Eli Lilly and Company, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Chao+GY%22">Chao GY</searchLink>; Eli Lilly and Company, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Ng+WT%22">Ng WT</searchLink>; Eil Lilly-NUS, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Mitchell+MI%22">Mitchell MI</searchLink>; Eli Lilly and Company, Windlesham, Surrey, UK.<br /><searchLink fieldCode="AU" term="%22Grau+G%22">Grau G</searchLink>; Eli Lilly and Company, Bad Homburg, Germany.<br /><searchLink fieldCode="AU" term="%22Kurek+R%22">Kurek R</searchLink>; Eli Lilly and Company, Bad Homburg, Germany.<br /><searchLink fieldCode="AU" term="%22LoRusso+P%22">LoRusso P</searchLink>; Yale University, New Haven, CT, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227806519%22">Cancer chemotherapy and pharmacology</searchLink> [Cancer Chemother Pharmacol] 2016 Aug; Vol. 78 (2), pp. 271-80. <i>Date of Electronic Publication: </i>2016 Jun 16. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase II; Journal Article; Multicenter Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>7806519 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-0843 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203445704%22">03445704 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Chemother Pharmacol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=27312733 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s00280-016-3074-y Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 271 Titles: – TitleFull: Evaluation of the effect of necitumumab on the corrected QT interval in patients with advanced solid tumors. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Smith DC – PersonEntity: Name: NameFull: Powderly J – PersonEntity: Name: NameFull: Lee JJ – PersonEntity: Name: NameFull: Shepard DR – PersonEntity: Name: NameFull: Wallin J – PersonEntity: Name: NameFull: Chaudhary A – PersonEntity: Name: NameFull: Chao GY – PersonEntity: Name: NameFull: Ng WT – PersonEntity: Name: NameFull: Mitchell MI – PersonEntity: Name: NameFull: Grau G – PersonEntity: Name: NameFull: Kurek R – PersonEntity: Name: NameFull: LoRusso P IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 08 Text: 2016 Aug Type: published Y: 2016 Identifiers: – Type: issn-electronic Value: 1432-0843 Numbering: – Type: volume Value: 78 – Type: issue Value: 2 Titles: – TitleFull: Cancer chemotherapy and pharmacology Type: main |
| ResultId | 1 |